KeyCorp (KEY) Pops 4.9% for February 15

Equities Staff |

One of the S&P 500’s big winners for Monday February 15 was KeyCorp (KEY) as the company’s stock climbed 4.9% to $10.49 on volume of 15.59 million shares.

The stock opened at $10.19 and saw an intraday low of $10.15 and an intraday high of $10.59. All told, the day saw a per-share gain of $0.49. The stock’s average daily volume of 16.04 million and 835.37 million shares outstanding. KeyCorp now has a 50-day SMA is $12.06 and 200-day SMA is $13.50, and it has a 52-week high of $15.70 and a 52-week low of $9.88.

KeyCorp is a bank holding company. The Company through its subsidiaries, provides retail and commercial banking, commercial leasing, investment management, consumer finance and investment banking products and services to its clients.

Based out of Cleveland, OH, KeyCorp has 0 employees and, after today’s trading, reached a market cap of $8.76 billion. The stock’s P/E Ratio is 9.6. Its P/S ratio is 1.86, P/B ratio is 0.84, and P/FCF ratio is 835.4.

For a complete fundamental analysis analysis of KeyCorp, check out’s Stock Valuation Analysis report for KEY. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and…

Private Markets

California Green Tree Development

California Green Tree Development LLC (CGTD) is a for-profit LLC that plans on using California’s booming market of legal cannabis products for medical purposes. As an unprecedented resource, Cannabis has…

Mesa-Marshall 2 Well Project

MESA Resources ("MESA") is sponsoring the development of the two well direct drilling project -- "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development of…